CC214-1
CC214-1 is a potentially efficacious mTOR inhibitor that induces autophagy [1], with an IC50 is 0.002 μM. CC214-1 proved to be useful as an in vitro tool compound for the exploration of mTOR kinase biology. CC214-1 can be used for Glioblastoma study[2].
Product Specifications
CAS Number
1021920-32-0
UNSPSC
12352005
Target
MTOR
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cc214-1.html
Purity
98.49
Solubility
DMSO : 20 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1NC2=NC=C(C3=CC=C(C4=NN=CN4)C=C3)N=C2N1CCC5CCOCC5
Molecular Formula
C20H21N7O2
Molecular Weight
391.43
References & Citations
[1]Gini B, et al. The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Clin Cancer Res. 2013 Oct 15;19 (20) :5722-32.|[2]Mortensen DS, et al. Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase. Bioorg Med Chem Lett. 2013 Mar 15;23 (6) :1588-91.|[3]Herrero-Sánchez MC, et al. Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control. Br J Haematol. 2016 Jun;173 (5) :754-68.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP311377M 100 µg
Cytochrome p450 2C19 (CYP2C19) (NM_000769) Human Recombinant Protein
Sign In for Pricing
View Details 
LY401597 100 µg
beta Defensin 1 (DEFB1) (NM_005218) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC742347-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rEGP40/1110), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 